Filing Flows

Filing Flows › National Health Investors (NHI) › Q2 2025

National Health Investors (NHI) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 6, 2025

National Health Investors (NHI) reported revenue of $90.7M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +2% from the quarter before. Operating margin was 40.5%, net earnings $37.0M (40.8% of revenue).

Revenue$90.7M
Year over year+7%
Quarter over quarter+2%
Operating margin40.5%
Net earnings$37.0M

National Health Investors, Q2 2025: revenue $90.7M (+7% year over year), operating margin 40.5%, net earnings $37.0M, operating cash flow $59.8M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$90.7M+2%+7%
Operating profit$36.7M+8%+5%
Net earnings$37.0M+8%+5%
Operating cash flow$59.8M+29%-2%
Free cash flow$57.2M+29%+0.1%

What changed

Revenue was $90.7M in Q2 2025, up 7% year over year and up 2% from the previous quarter.

Operating profit was $36.7M, a 40.5% margin (down 0.7 points year over year). Of the extra revenue versus a year earlier, 31% reached operating profit, below the 41% margin then. Total costs grew 8% against revenue growth of 7%. The fastest-growing cost line was General & admin (+26%). Net earnings were $37.0M, up 5% year over year ($36.7M including minority interests, which bore $298K of losses). The effective tax rate was 0.0%.

Operating cash flow was $59.8M (down 2% year over year), 163% of net earnings. Non-cash charges added back $19.9M of depreciation and $1.1M of share-based compensation. Capital expenditures of $2.6M left free cash flow of $57.2M.

Questions

What was National Health Investors' revenue in the second quarter 2025?

National Health Investors (NHI) reported revenue of $90.7M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +2% from the quarter before.

Was National Health Investors profitable in the second quarter 2025?

Operating profit was $36.7M (40.5% of revenue) and net earnings $37.0M.

Open the interactive Sankey →

Source: National Health Investors 10-Q on SEC EDGAR.